Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis

Clinical trial NCT06766461 · RECRUITING

Trial details

NCT number: NCT06766461
Sponsor: Erasmus Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sepsis - to Reduce Mortality in the Intensive Care Unit Sepsis Septic Shock

Start date: 2025-01-03
Primary completion: 2026-12-01
Enrollment: 980

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.